Sioud Mouldy
The Norwegian Radium Hospital, Department of Immunology, Molecular Medicine Group, Montebello, N-310, Oslo, Norway.
Trends Pharmacol Sci. 2004 Jan;25(1):22-8. doi: 10.1016/j.tips.2003.11.006.
The ability of small-interfering RNAs (siRNAs) to silence gene expression in somatic mammalian cells has provided researchers with a novel tool to block the expression of disease-causing genes, provided that their mRNA sequences are known. siRNAs can be delivered to cells either exogenously as synthetic agents or endogenously as gene-encoding siRNAs. Recent studies demonstrate the general application of siRNAs to silence gene expression in a range of cell types and in whole mammals. Beyond their value for dissecting gene functions and target validation, siRNAs also hold great potential as gene-specific therapeutic agents.
小干扰RNA(siRNA)在哺乳动物体细胞中使基因表达沉默的能力,为研究人员提供了一种新型工具,用于阻断致病基因的表达,前提是其mRNA序列已知。siRNA可以作为合成剂外源递送至细胞,也可以作为编码基因的siRNA内源递送至细胞。最近的研究表明,siRNA在一系列细胞类型和整个哺乳动物中使基因表达沉默具有广泛的应用。除了在剖析基因功能和靶点验证方面的价值外,siRNA作为基因特异性治疗剂也具有巨大潜力。